XML 50 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment reporting (Tables)
 6 Months Ended
Feb. 28, 2018
Segment Reporting [Abstract]  
Reconciliation of Revenue from Segments to Consolidated
The following table reflects results of operations of the Company’s reportable segments (in millions):
 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Three months ended February 28, 2018
 
 
 
 
 
 
 
 
 
Sales to external customers
$
24,478

 
$
3,317

 
$
5,226

 
$
—

 
$
33,021

Intersegment sales
—

 
—

 
529

 
(529
)
 
—

Sales
$
24,478

 
$
3,317

 
$
5,755

 
$
(529
)
 
$
33,021

 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
1,649

 
$
280

 
$
231

 
$
3

 
$
2,163

 
 
 
 
 
 
 
 
 
 
Three months ended February 28, 2017
 

 
 

 
 

 
 

 
 

Sales to external customers
$
21,814

 
$
3,101

 
$
4,531

 
$
—

 
$
29,446

Intersegment sales
—

 
—

 
499

 
(499
)
 
—

Sales
$
21,814

 
$
3,101

 
$
5,030

 
$
(499
)
 
$
29,446

 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
1,552

 
$
242

 
$
226

 
$
(4
)
 
$
2,016

 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Six months ended February 28, 2018
 
 
 
 
 
 
 
 
 
Sales to external customers
$
46,967

 
$
6,400

 
$
10,394

 
$
—

 
$
63,761

Intersegment sales
—

 
—

 
1,079

 
(1,079
)
 
—

Sales
$
46,967

 
$
6,400

 
$
11,473

 
$
(1,079
)
 
$
63,761

 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
3,026

 
$
490

 
$
455

 
$
1

 
$
3,972

 
 
 
 
 
 
 
 
 
 
Six months ended February 28, 2017
 
 
 
 
 
 
 
 
 
Sales to external customers
$
42,473

 
$
6,063

 
$
9,411

 
$
—

 
$
57,947

Intersegment sales
—

 
—

 
1,036

 
(1,036
)
 
—

Sales
$
42,473

 
$
6,063

 
$
10,447

 
$
(1,036
)
 
$
57,947

 
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
2,841

 
$
455

 
$
450

 
$
(4
)
 
$
3,742
Reconciliation of Operating Income (Loss) from Segments to Consolidated
The following table reconciles adjusted operating income to operating income (in millions):
 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Three months ended February 28, 2018
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
1,649

 
$
280

 
$
231

 
$
3

 
$
2,163

Acquisition-related amortization
 

 
 

 
 

 
 

 
(113
)
Acquisition-related costs
 

 
 

 
 

 
 

 
(65
)
Certain legal and regulatory accruals and settlements
 

 
 

 
 

 
 

 
(90
)
LIFO provision
 

 
 

 
 

 
 

 
(43
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
113

Asset recovery
 
 
 
 
 
 
 
 
15

Operating income
 

 
 

 
 

 
 

 
$
1,980

 
 
 
 
 
 
 
 
 
 
Three months ended February 28, 2017
 

 
 

 
 

 
 

 
 

Adjusted operating income
$
1,552

 
$
242

 
$
226

 
$
(4
)
 
$
2,016

Acquisition-related amortization
 

 
 

 
 

 
 

 
(82
)
Acquisition-related costs
 
 
 
 
 
 
 
 
(29
)
LIFO provision
 

 
 

 
 

 
 

 
(49
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(37
)
Cost transformation
 
 
 
 
 
 
 
 
(340
)
Operating income
 

 
 

 
 

 
 

 
$
1,479

 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Six months ended February 28, 2018
 
 
 
 
 
 
 
 
 
Adjusted operating income
$
3,026

 
$
490

 
$
455

 
$
1

 
$
3,972

Acquisition-related amortization
 

 
 

 
 

 
 

 
(198
)
Acquisition-related costs
 

 
 

 
 

 
 

 
(116
)
Certain legal and regulatory accruals and settlements
 

 
 

 
 

 
 

 
(115
)
LIFO provision
 

 
 

 
 

 
 

 
(97
)
Hurricane-related costs
 
 
 
 
 
 
 
 
(83
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(76
)
Asset recovery
 
 
 
 
 
 
 
 
15

Operating income
 

 
 

 
 

 
 

 
$
3,302

 
 
 
 
 
 
 
 
 
 
Six months ended February 28, 2017
 

 
 

 
 

 
 

 
 

Adjusted operating income
$
2,841

 
$
455

 
$
450

 
$
(4
)
 
$
3,742

Acquisition-related amortization
 

 
 

 
 

 
 

 
(164
)
Acquisition-related costs
 
 
 
 
 
 
 
 
(46
)
LIFO provision
 

 
 

 
 

 
 

 
(107
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(78
)
Cost transformation
 

 
 

 
 

 
 

 
(421
)
Operating income
 

 
 

 
 

 
 

 
$
2,926